Literature DB >> 1689406

[Current status of treatment of renal cell carcinoma and future problems].

Y Satomi1.   

Abstract

An account was given of the current status of treatment of renal cell carcinoma and reference made to problems that remain unsolved as follows: (1) Failure to keep biological characteristics of renal cell carcinoma in mind may be misleading in deciding on a therapeutic policy, (2) already established as it may appear, operation for renal cell carcinoma is still open to discussion, (3) indication for operation upon metastatic lesions, (4) widespread use of interferon based on insufficient theoretical grounds to provide ample justification, (5) future development and possible usefulness of multiple drug combination therapy including interferon as a main component and (6) how to make best use of neo-adjuvant therapy for renal cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1689406     DOI: 10.5980/jpnjurol1989.81.1

Source DB:  PubMed          Journal:  Nihon Hinyokika Gakkai Zasshi        ISSN: 0021-5287


  2 in total

1.  Expression of globo-series gangliosides in human renal cell carcinoma.

Authors:  S Saito; S Orikasa; M Satoh; C Ohyama; A Ito; T Takahashi
Journal:  Jpn J Cancer Res       Date:  1997-07

2.  A Case of Obstructive Jaundice Caused by Metastasis of Ovarian Cancer to the Duodenal Major Papilla.

Authors:  Yusuke Takasaki; Atsushi Irisawa; Goro Shibukawa; Ai Sato; Yoko Abe; Akane Yamabe; Noriyuki Arakawa; Takumi Maki; Yoshitsugu Yoshida; Ryo Igarashi; Shogo Yamamoto; Tsunehiko Ikeda; Nobutoshi Soeta; Takuro Saito; Hiroshi Hojo
Journal:  Clin Med Insights Case Rep       Date:  2018-08-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.